Cell salvage during liver transplantation for hepatocellular carcinoma: a retrospective analysis of tumour recurrence following irradiation of the salvaged blood

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022096

Enrollment

Registered

2023-01-18

Start date

2019-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Group 1: The goal of the study was to evaluate whether patients who received intraoperative irradiated cell salvaged blood during LTx due to HCC had a higher rate of tumour recurrence than patients wh

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Liver transplantation due to hepatocellular carcinoma

Exclusion criteria

Exclusion criteria: no hepatocellular carcinoma, < 18 years

Design outcomes

Primary

Measure	Time frame
retrospective, tumor recurrence	—

Secondary

Measure	Time frame
retrospective, mortality	—

Countries

Germany

Contacts

Public ContactBarbara Sinner

Klinik für Anästhesiologie, Universitätsklinikum Regensburg

barbara.sinner@ukr.de0049 941 944 7801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026